Leadership: Page 25


  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Gen Y - Gen How

    Whether you want to hire them or sell them a product, meeting the needs of ­Millennials requires new strategies.   As the newest generation of healthcare consumers and employment pool, the Gen Y population — all 77 million of them — want you to know something. They want to be happy, they want to ...

    By Robin Robinson • Feb. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Year in Preview: On the Horizon: Looking Ahead…

    Experts from across all sectors of the industry provide their input on the trends in 2015 that will have the biggest impact on the industry, and how they will shape the future of healthcare. For this year’s special Year in Preview issue we took a slightly different tact than in years past. We are...

    By Taren Grom • Nov. 15, 2014
  • clinical trial diversity Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS The mHealth Summit, Dec. 7-11, convenes an array of healthcare stakeholders focused on the integration of mHealth and wireless solutions to improve systemic healthcare systems, patient outcomes, and acces...

    By PharmaVoice Team • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers & Scientists

    Dr. Rob Kotin Seeing the Big Picture in Gene Therapy Driven to innovate by Curiosity One of the most influential thought leaders in gene therapy today, Rob Kotin, Ph.D.’s work has the potential to make a lasting impact on the lives of patients suffering from debilitating diseases of the central n...

    By PharmaVoice Team • Nov. 6, 2014
  • Trendline

    The latest tech powering clinical trials

    Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.